Home > Insider Trading > Filing (0001209191-13-031061)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876343	Biotime Inc	BTX	Biological Products, (No Disgnostic Substances) (2836)	943127919

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1470741	Pedro Lichtinger	1301 Harbor Bay Parkway Alameda CA 94502		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Acquisiton	2013-06-04	120,000	$0.00	126,250	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Option to Purchase Common Shares	Acquisiton	2013-06-04	30,000	$0.00	30,000	$5.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,000	2013-06-04	2018-06-04	No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Option to Purchase Common Shares	$4.60	2017-06-30	20,000	20,000	Direct
Common Shares	Option to Purchase Common Shares	$5.13	2016-06-30	20,000	20,000	Direct
Common Shares	Option to Purchase Common Shares	$5.45	2015-08-09	20,000	20,000	Direct
Common Shares	Option to Purchase Common Shares	$3.45	2014-08-10	20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-06-30	20,000	20,000	Direct
2016-06-30	20,000	20,000	Direct
2015-08-09	20,000	20,000	Direct
2014-08-10	20,000	20,000	Direct

Footnotes

On June 4, 2013, Mr. Lichtinger purchased 120,000 BioTime common shares and 30,000 options to purchase 30,000 common shares in a private transaction. Each common share and one quarter of each option were purchased for an aggregate price of $4.155.
Does not include shares that may be acquired upon the exercise of certain stock options.
5,000 options became exercisable on September 30, 2012; December 31, 2012;and March 31, 2013. 5,000 options will become exercisable on June 30, 2013 based upon continued service on the board of directors.
5,000 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.
5,000 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.
5,000 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.